CFO4Life Group’s Abbott ABT Stock Holding History

CFO4Life Group’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,064	Closed	-$259K	–	211
2025 Q4	$259K	Sell	2,064 -224	-10%	-$28.5K	0.04%	199
2025 Q3	$306K	Sell	2,288 -12	-0.5%	-$1.57K	0.04%	169
2025 Q2	$313K	Buy	2,300 +93	+4%	+$12.3K	0.05%	163
2025 Q1	$293K	Buy	2,207 +132	+6%	+$16.8K	0.05%	161
2024 Q4	$235K	Buy	2,075 +193	+10%	+$22.3K	0.04%	184
2024 Q3	$215K	Buy	+1,882	New	+$206K	0.04%	194
2024 Q1	–	Sell	-1,827	Closed	-$201K	–	201
2023 Q4	$201K	Buy	+1,827	New	+$183K	0.04%	168
2022 Q3	–	Sell	-2,065	Closed	-$221K	–	155
2022 Q2	$221K	Buy	2,065 +68	+3%	+$7.72K	0.05%	131
2022 Q1	$236K	Sell	1,997 -531	-21%	-$65.8K	0.05%	135
2021 Q4	$356K	Buy	2,528 +266	+12%	+$34K	0.07%	112
2021 Q3	$267K	Buy	+2,262	New	+$278K	0.06%	120
2019 Q1	–	Sell	-4,140	Closed	-$299K	–	123
2018 Q4	$299K	Buy	4,140 +1,018	+33%	+$71.5K	0.13%	89
2018 Q3	$229K	Buy	+3,122	New	+$205K	0.1%	112

Other funds holding ABT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CFO4Life Group's ABT Position: Q1 2026 in Review

CFO4Life Group sold out of Abbott (ABT) in Q1 2026, closing a stake of 2,064 shares — an estimated $259K sold.

CFO4Life Group first reported a position in ABT in Q3 2018 and held it in 13 quarters. The position peaked at $356K in Q4 2021. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

CFO4Life Group reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
CFO4Life Group sold 2,064 Abbott shares in Q1 2026, an estimated $259K.
CFO4Life Group first reported a position in Abbott in Q3 2018 and held it in 13 quarters.
CFO4Life Group's Abbott position peaked at $356K in Q4 2021.
3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on CFO4Life Group's 13F filing for Q1 2026, filed 11 May 2026.